Clinical Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2005; 11(44): 7001-7006
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.7001
Figure 1
Figure 1 Patients: Analysis sets and drop outs.
Figure 2
Figure 2 Patients (ITT analysis) in clinical remission or improved during a 4-mo follow-up period without additional apheresis therapy.
Figure 3
Figure 3 Course of clinical and endoscopic activity indices (CAI, EI) throughout the apheresis treatment. aP<0.05 vs Et at wk 6, bP<0.01 vs Et at wk 5, dP<0.01 vs Et at wk 4, fP<0.05 vs Et at wk 3.
Figure 4
Figure 4 Course of neutrophil, lymphocyte, and monocyte counts as well as CRP between the beginning and wk 6 of the study (numbers are given as means; no significant differences).